Avanos Medical, Inc. (AVNS)

NYSE: AVNS · Real-Time Price · USD

15.46

+0.25 (1.64%)

At close: Feb 20, 2026, 4:00 PM EST

15.60

+0.14 (0.91%)

After-hours: Feb 20, 2026, 7:00 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Medical Devices	687.80M	673.30M	684.10M	587.00M	714.80M
Medical Devices Growth	2.15%	-1.58%	16.54%	-17.88%	2.47%
Total	687.80M	673.30M	684.10M	587.00M	714.80M
Total Growth	2.15%	-1.58%	16.54%	-17.88%	2.47%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
North America	545.00M	537.90M	552.00M	449.10M	-
North America Growth	1.32%	-2.55%	22.91%	-	-
Europe, Middle East and Africa (EMEA)	94.80M	84.10M	77.40M	86.10M	108.30M
Europe, Middle East and Africa (EMEA) Growth	12.72%	8.66%	-10.10%	-20.50%	13.05%
Asia Pacific and Latin America	48.00M	51.30M	54.70M	51.80M	71.00M
Asia Pacific and Latin America Growth	-6.43%	-6.22%	5.60%	-27.04%	5.81%
United States	-	-	-	-	481.60M
United States Growth	-	-	-	-	0.08%
North America (Excl. United States)	-	-	-	-	53.90M
North America (Excl. United States) Growth	-	-	-	-	0.75%
Total	687.80M	673.30M	684.10M	587.00M	714.80M
Total Growth	2.15%	-1.58%	16.54%	-17.88%	2.47%

Source: S&P Global Market Intelligence.